A Study of LY3200882 in Participants With Solid Tumors
Phase 1 – testing safety in a small group of people
Conditions:
Solid Tumor
Sponsor: Eli Lilly and Company
trial.available_in:
БГ
Overview
The main purpose of this study is to evaluate the safety of the study drug known as LY3200882 in participants with solid tumors.
Who can participate
Inclusion Criteria:
* The participant must have histological or cytological evidence of cancer.
* Have adequate organ function.
* Have Eastern Cooperative Oncology Group (ECOG) scale performance status of 0 or 1.
* Are able to swallow capsules and tablets.
Exclusion Criteria:
* Have moderate or severe cardiovascular disease.
* Have a serious concomitant systemic disorder.
* Have acute leukemia.
БГ